This study investigates the following two questions: (1) Should the DNA analyst concentrate the DNA extract into a single amplification or should he/she split it up to do two replicates? (2) Given the electropherogram obtained from a first analysis, is it worthwhile for the DNA analyst to invest in obtaining a second replicate? A decision-theoretic approach addresses these questions by quantitatively expressing the expected net gain (ENG) of each DNA analysis of interest. The results indicate that two replicates generally have a greater ENG than a single DNA analysis for DNA quantities capable of producing two replicates having an average allelic peak height as low as 43 rfu. This supports the position that two replicates increase the information content with regard to a single analysis.
1. Introduction
Background
Interpreting low-template DNA (lt-DNA) typing results is challenging because of the increased influence of stochastic effects [e.g., 1]. These stochastic effects can produce a configuration of peaks in the electropherogram (EPG) that is different from the genotype of the DNA's donor. We speak of allele drop-out (or locus drop-out) when one (or both) of the donor's alleles fail(s) to produce a signal in the EPG for a particular locus, and of allele drop-in when a signal for an allele not present in the donor's genotype appears in the EPG. Probabilistic models [e.g., 2] can take the possibility of these stochastic effects into account when assigning the weight of the evidence by modeling the probabilities of allele drop-out [e.g., 3] and allele drop-in [e.g., 4].
To deal with the uncertainty produced by the stochastic effects, a laboratory may perform replicate analyses [1, 2] . This involves dividing the DNA into several tubes prior to amplification to produce multiple EPGs (one per tube) for the same sample. The motivation for doing replicates is that the stochastic effects will vary from one replicate to another, so that multiple EPGs may provide more information about the donor's genotype. Benschop et al. [5] and Cowen et al. [6] conclude that replicate analyses combined with a consensus interpretation method (also called biological model) increases the proportion of the donor's genotype that is observed. And according to Steele et al. [7] , multiple replicates produce more information than the single profile when a probabilistic interpretation model (also called statistical model) is applied.
Yet, there has been some debate on whether this multiple tube approach provides more information than concentrating the entire DNA sample into a single tube [8, 9, 10] . On the one hand, putting all of the DNA into the same tube may produce an EPG showing fewer allele and locus drop-outs [8] . On the other hand, splitting it into multiple tubes may provide more data for making inferences about the stochastic effects and the donor's genotype [9] .
In addition to considering the value of the information produced by each of these two approaches, however, there is also the laboratory's resources to consider. Replicate analyses (i.e., the multiple tube approach) require more resources than performing a single analysis.
This paper investigates the decision of whether it is worth investing in replicates by applying a decision-theoretic approach.
Objective
The objective of this study is to examine the following two questions:
1. all in vs. two replicates: Should the DNA analyst concentrate the DNA extract into a single amplification or should he/she split it up into two tubes to obtain two replicates? 2. additional replicate: Given an EPG obtained from a first analysis, is it worthwhile for the DNA analyst to invest in obtaining a second replicate?
The answers to these questions depend on the expected value of information (EVOI) and the laboratory's cost of performing the DNA analyses. Decision theory provides a framework for determining the most rational course of action based on these two values. This paper is organized as follows: Section 2 describes the methodology of this study, Section 3 presents the results obtained, Section 4 discusses the impact of the various parameters on the results, and Section 5 presents a summary and concluding remarks. The mathematical description of the decision-theoretic model used is in Appendix A.
Materials and methods
This study consisted of:
1. obtaining DNA profiles for a range of low-level DNA quantities, 2. defining a probabilistic model and its parameters for making inferences on the donor's genotype and on the expected DNA typing results, and 3. defining a decision-theoretic model for quantitatively expressing the EVOI of the DNA typing results.
Points 1 and 2 are described in detail in [11] . This section summarizes points 1 and 2 and describes point 3.
DNA analyses
EPGs of single-source DNA samples were obtained for DNA quantities of 10 pg, 7.5 pg, 5 pg, 2.5 pg, 1 pg, 0.75 pg, 0.5 pg and 0.25 pg. This range was chosen because it created EPGs ranging from having no allele or locus drop-outs to showing all loci dropping out. 1 Two kits were used for the DNA amplification: AmpFlSTR Identifiler Plus (29 cycles) and PowerPlex 16 HS by Promega (32 cycles). Capillary electrophoresis separated and detected the PCR products on am ABI 3130xl genetic sequencer. GeneMapper ID-X software version 1.3 by Applied Biosystems was used for analyzing the DNA typing results. For further details on the analytical procedure, we refer the reader to [11] .
Probabilistic Model
A semi-continuous model was used for making inferences on the donor's genotype and on the expected DNA typing results using the equations presented in [2] and the probability assignments listed below:
allele probabilities: point estimates using the allele frequency data presented in [12] ; probability of allele drop-out: a logistic regression model for variable ln(Ĥ) and the parameter values given in [11] , whereĤ is the average observed peak height in the EPG; and probability of allele drop-in per locus: values of 0.01 and 0.05 (a set of decision analyses is performed for each value).
We used the R software 2 to perform the computations. For further details on the probabilistic model, we refer the reader to [11] . 1 Analytical threshold of 10 rfu 2 R version 3.1.2, freely available at http://cran.r-project.org/ (last visited April 26, 2015)
Decision theoretic model
The goal of performing DNA analyses is to obtain information about the genotype of the DNA's donor. The analyst has a probability distribution over the donor's possible genotypes, and the information provided by the DNA typing results updates this probability distribution. Yet, alone, this probability distribution does not tell the analyst how to "designate" the donor's genotype, that is, what genotype to assign so that the analyst can compare the DNA typing results with the genotypes of potential donors and exclude the ones that do not fit the designation. This genotype designation process is a decision [13] . The analyst chooses a designation based on the probability distribution over the donor's possible genotypes and the utility function describing the benefit of a correct designation and the cost of an incorrect designation. Making a rational decision requires choosing the designation that maximizes the expected utility [e.g., 14]. For decisions about performing or not performing DNA analyses and what DNA analyses to perform, a rational decision-maker requires the expected net gains (ENGs) of the analyses in question. Let us call the DNA analysis of interest t * . The ENG of DNA analysis t * is equal to the EVOI of t * minus the cost of performing t * :
A rational decision-maker will choose the action that maximizes the ENG [15] . If the ENG(t * ) is negative, performing no DNA analysis is more rational, because the ENG of performing no analysis is equal to zero. The mathematical development for this decision-theoretic model for the DNA analyses of interest in this study is given in Appendix A.
The EVOI of a DNA analysis (Eqs. (A.2) and (A.3) in Appendix A) depends on the probabilistic model (see Section 2.2) and the utility function. We discuss the utility function below.
Utility function
There are three types of genotype designations for each locus:
complete: a complete designation that names two alleles, for example {7, 8};
partial: a designation that specifies only one allele and uses a wildcard F for the other allele, where F represents any allele at this locus, for example {7, F}; and uninformative: an uninformative designation {F, F}, that is, a designation that does not specify any allele at this locus.
For each locus, the designation of a genotype can lead to four possible outcomes: A utility function describes an analyst's preferences among these outcomes. We define a cardinal utility function 3 which specifies two things:
1. preference structure: the relative costs and benefits of each of the possible outcomes to each other, for example a correct complete designation is two times more desirable than a correct designation with F; and 2. magnitude: the absolute cost or benefit of each outcome, for example the utility of a correct complete designation is 100 utiles 4 .
The preference structure determines what action maximizes the expected utility. In this study, we used two different preference structures, which we call the symmetric preference structure and the conservative preference structure. Rows 1 and 2 in Table 1 present these on a scale from 0 to 1. Both of these preference structures assume that the decision-maker is indifferent between the following two hypothetical gambles (i.e., they both assume probabilities of 0.5 and 0.5 in gamble 1): gamble 1: obtain a correct complete designation with a probability of 0.5 and an uninformative designation {F, F} with a probability of 0.5 gamble 2: obtain a correct partial designation with certainty
The two preference structures differ in the value they assign to x to make the decision-maker indifferent between the following two gambles (i.e., they assume different probabilities in gamble 1, represented here by x and 1 − x, and the value of x for each is presented below):
gamble 1: obtain a correct complete designation with a probability of x and an incorrect designation with a probability of 1 − x gamble 2: obtain an uninformative designation {F, F} with certainty For the symmetric preference structure x = 0.5, and for the conservative preference structure x = 0.9. The conservative preference structure is more conservative because switching from an uninformative designation to a designation that specifies the alleles requires a higher probability that the allelic designation will be correct. So this preference structure penalizes an incorrect designation more than the symmetric preference structure does. The preference structure encapsulates the decision-maker's risk-taking behavior with regard to the risk of a false exclusion and the risk of a false inclusion. Lowering one risk increases the other. So the most acceptable preference structure is the most desirable balance between these two risks, which should be based on the economic and social costs involved [18] . In this case, the conservative preference structure leads to a smaller probability of a false exclusion and a larger probability of false inclusion, and the symmetric preference structure leads to a smaller probability of false inclusion and a larger probability of false exclusion. In casework, the severity of the committed crime may determine the preference structure of the forensic scientist's utility function: the more severe the crime is, the more conservative the preference structure because the greater the forensic scientist's desirability of reducing the probability of a false exclusion. The magnitude of the utility function specifies how large the maximum expected utility is, and therefore how large the EVOI is. To quantitatively express the ENG on a monetary scale, it is necessary to define the magnitude of the utility function on this same monetary scale. In this paper we use US dollars as the monetary scale. We define magnitude m as the gain in dollars of a correct complete designation for one locus. Centering our utility function at 0 for the uninformative designation {F, F} (i.e., an uninformative designation produces zero gain and zero loss), this means that a correct partial designation produces a gain of m 2 dollars, and an incorrect designation yields a loss of −m dollars in the symmetric preference structure and a loss of −9m dollars in the conservative preference structure (rows 3 and 4 in Table 1 ) for one locus. The magnitude of the utility function in a particular case requires considering the monetary costs of false inclusions and false exclusions. This is a difficult concept to quantify. It includes investigative costs of investigating potential donors. The investigative resources a police force can invest for a particular case may, again, depend on the severity of the committed crime. If it can be assumed that the DNA was left by the offender, then m can also include society's costs with regard to letting the offender go free and convicting an innocent person. In this case, m can depend on:
• the probability of re-offending: the higher this probability, the greater the cost of a false exclusion; 4 A utile is a basic unit of measurement of utility [17] . Table 1 : The symmetric utility function and the conservative utility function shown here on a scale from 0 to 1 (rows 1 and 2) and on a monetary scale where the utility of an uninformative designation {F, F} is set to 0 and m represents the magnitude.
• the seriousness of the committed crime: the more serious the committed the crime, the greater the cost of a false exclusion (in particular if the probability of re-offending is high); and
• if the DNA is the only piece of evidence and can lead to a conviction, then the expected sentence for the committed crime: the more severe the sentence, the greater the cost of a false inclusion.
To avoid focusing on any one scenario, this study performed the decision analyses for a range of values of m, consisting of 1, 10, 100, 1000 and 10, 000.
Note that this utility function assigns a loss or gain for the genotype designation at one locus, and the DNA profiles we are considering consist of 15 loci. So the maximum gain and loss for an entire genotype (i.e., for 15 loci) are equal to 15 times the values presented here.
Cost of DNA analyses
Quantitatively expressing the ENG requires specifying the cost of the DNA analysis of interest. To answer the two questions presented in Section 1.2, we need the cost of performing a single DNA analysis for the sample and the cost of performing two replicate analyses for this sample. We define cost c 1 as the cost in US dollars of a single DNA analysis, and cost c 2 as the cost in US dollars of two replicate analyses.
If we consider only the cost of the DNA analysis kits, we estimate the cost of one DNA analysis as $45. 5 The cost of two replicates would be a maximum of $90, but most likely less since the quantification and extraction stages would be performed only once.
If we attempt to consider the total cost of one DNA analysis, that is if we take into account the labor, the equipment, facilities, etc. in addition to the DNA analysis kits, the cost values would be much higher. To see how the results of the decision analysis vary in function of the costs, we repeated the decision analysis for costs of $450 for one DNA analysis and $900 for two replicates. The cost of $900 for two replicates assumes again that performing two replicates uses twice as many resources as one analysis. This is the maximum cost for two replicates. The real cost is most likely smaller. For this reason we repeated this decision analysis for a cost of $600 for two replicates (which considers the additional cost of the second replicate to be $150, or 1 3 of the cost of a single analysis).
All in vs. two replicates
We obtained numerical values for the ENG of a single DNA analysis of a quantity q of DNA, denoted ENG(t 1,q ), and the ENG of two replicate analyses, each for a quantity ). We performed this decision analysis for q of what we quantified as ≈10 pg, ≈5 pg, ≈1 pg and ≈0.5 pg. For such small quantities of DNA, these quantification values should be taken with caution. So instead of presenting the results in function of the quantity of DNA, we present the results in function of the average observed peak height of an allele in the resulting EPG (Table 2) . We compared the ENG of one DNA analysis for each of the average peak heights q with the ENG of two replicates, each with the average peak height of q 2 . We assessed EVOI(t 1,q ) and EVOI(t 2, q 2 ) in R using Eq. A.2 (in Appendix A). 5 The authors thank Jo-Anne Bright and Todd Bille for their valuable insight that helped inform this value. ), for each of these quantities. The larger EVOI is highlighted in bold if it is larger for all situations represented in that row.
Additional replicate
We obtained numerical values for the ENG of a second replicate given the DNA typing results of a first DNA analysis, denoted ENG(t +1 ). We performed this decision analysis for the entire range of the DNA dilution series (see Section 2.1 and Section 2.1.1. in [11] ), assuming that the second replicate would have the same expected average allelic peak height as the first analysis. We assessed EVOI(t +1 ) in R using Eq. A.3 (in Appendix A).
Results

All in vs. two replicates
We note that the average peak heights are about twice as large for the PowerPlex 16 HS results than for the Identifiler Plus results (Table 2 ). This is a consequence of the difference in the manufacturer's recommended amplification cycle number (i.e., 29 cycles for Identifiler Plus and 32 cycles for PowerPlex 16 HS). These mean average peak heights determined the probability of allele drop-out (see Eq. (1) in [11] ) used in the probabilistic part of the model.
Comparing the EVOI obtained for a single analysis with the EVOI obtained for two replicates for each of the four quantities of DNA produced the following results (Table 2) :
Identifiler Plus: The EVOI of a single analysis is greater than the EVOI of two replicates for quantities 1 and 2, and smaller than the EVOI of two replicates for quantities 3 and 4.
PowerPlex 16 HS:
The EVOI of a single analysis is greater than the EVOI of two replicates for quantity 1, and smaller than the EVOI of two replicates for quantities 3 and 4. For quantity 2, the EVOI of a single analysis is smaller than the EVOI of two replicates for all of the scenarios studied except for the scenario of a conservative preference structure with a probability of allele drop-in of 0.05. In this scenario, the EVOI of a single analysis is greater than the EVOI of two replicates.
Examining these results with regard to the mean average allelic peak heights for each of the DNA quantities leads to the following observations. The EVOI of a single analysis is greater than the EVOI of two replicates when the average peak height in an EPG of a single analysis is 43 rfu or less (this corresponds to the average peak height in each of two replicates being about 20 rfu or less). The EVOI of two replicates is greater than the EVOI of a single analysis when the average peak height in an EPG of a single analysis is 287 rfu or more (this corresponds to the average peak height in each of two replicates being about 114 rfu or more). The threshold where the EVOI of two replicates becomes greater than the EVOI of a single analysis lies around an average peak height in an EPG of a single analysis of about 95 rfu (this corresponds to the average peak height in each of two replicates being around 43 rfu). At this threshold, the utility function's preference structure and the value of the probability of allele drop-in determine which analysis has the greater EVOI.
Combining the EVOI of the DNA analyses with their costs produces the ENGs presented in Figs When m is two orders of magnitude smaller than c 1 and c 2 , the ENG of both a single analysis and two replicates are negative. This indicates that the most rational choice is not to perform any DNA analysis.
As m increases with regard to c 1 and c 2 , the EVOIs of one and two replicates become greater than their costs, and the EVOI of the DNA analyses become dominant in determining the most rational choice. Hence, we find that the most rational choices for the situations where m is at least the same order of magnitude as c 1 and c 2 correspond to the DNA analyses with the greater EVOI.
Going from a symmetric preference structure to a conservative preference structure increases the threshold value of the average allelic peak height where performing two replicates becomes more rational than a single analysis.
Increasing the probability of allele drop-in from 0.01 to 0.05 has a negligible effect for Identifiler Plus and causes a slight increase of the threshold average allelic peak height value for PowerPlex 16 HS. The graphs in these figures show a concave increase of the ENG with regard to the average allelic peak height. For the DNA samples quantified at about ≈0.25 pg to ≈2.5 pg, the ENG of an additional replicate decreases as the average allelic peak height of the first DNA analysis's EPG increases. So for these quantities, the ENG is at its greatest when the first amplification fails completely, because that's when the second replicate can produce the largest amount of additional information. For all DNA samples quantified at about ≈5 pg and greater, there is an expectation of obtaining a complete profile. This causes the ENG of a second replicate to stop increasing in function of the DNA's quantitation and plateau in the graphs.
Additional replicate
An ENG greater than 0 indicates that it is rational to do a second replicate. With regard to this threshold, the graphs in these figures fall into three categories.
1. m is at least one order of magnitude smaller than c 1 : The cost of an additional replicate is always greater than the EVOI of the additional DNA typing results, producing a negative ENG. In this case, it is not rational to do a second replicate. 2. m is the same order of magnitude as c 1 : The cost of an additional replicate is greater than the EVOI of the additional replicate for small quantities of DNA, and smaller than the EVOI of the additional replicate for larger quantities of DNA. The threshold between these two situations is marked by the horizontal dashed line at 0 in these graphs. This threshold is at quantities of DNA having a mean average peak height of 43 rfu. In the situation where the utility function has a conservative preference structure and the probability of allele drop-in is 0.05, the ENG is positive for the majority (Identifiler Plus) or all (PowerPlex 16 HS) analyzed samples of the threshold quantity. In this situation, it seems to be rational to do a second replicate whenever the DNA quantity falls into a category having a mean average allelic peak height of ≥43 rfu. For all other situations, the ENG can be positive or negative for the analyzed samples of the threshold quantity. In these situations, it is rational to do a second replicate if the DNA quantity falls into a category having a higher mean average allelic peak height than the threshold quantity (e.g., ≥114 rfu for Identifiler Plus and ≥82 rfu for PowerPlex 16 HS). 3. m is at least one order of magnitude greater than c 1 : In the majority of the cases, the EVOI of the additional replicate is greater than the cost of a second replicate, producing a positive ENG. In these cases, it is rational to do a second replicate. The exceptions are for extremely small quantities of DNA. For Identifiler Plus, these are quantities where the mean average peak height is ≤18 rfu when the utility function has a conservative preference structure, and quantities where the mean average peak height is ≤8 rfu when the utility function has a symmetric preference structure. For PowerPlex 16 HS, the exceptions are quantities where the mean average peak height is ≤21 rfu when the utility function has a conservative preference structure and m is one order of magnitude greater than c 1 . In these cases, the ENG can be negative, so that it is not rational to do a second replicate.
Going from a symmetric preference structure to a conservative preference structure lowers the threshold for category 2 when the probability of allele drop-in is 0.05, and causes a very slight increase of the threshold for category 3.
Increasing the probability of allele drop-in from 0.01 to 0.05 lowers the threshold for the scenarios in category 2 when the preference structure is conservative.
Discussion
First we note that it is not worth performing any DNA analysis when m is more than one order of magnitude smaller than the cost. Such small values of m represent low costs of false inclusions and false exclusions. This occurs in cases of extremely minor offenses and in cases where there is a large uncertainty on the relevance of the DNA. The EVOI of the DNA analyses becomes overpowered by their costs, so that a decision analysis favors the choice with the smallest cost: not perform any DNA analysis.
For more serious cases with relevant biological samples, the model's results correspond with the expectation that two replicates produce more information than a single analysis. This result holds down to very small quantities of DNA. The threshold where the optimal choice switches from two replicates to a single analysis is around the point where the average allelic peak height in a replicate is 43 rfu, if the laboratory uses an analytical threshold between 10 rfu and 50 rfu.
In the additional replicate study, the threshold drops to 20 rfu or less when m is at least one order of magnitude greater than the cost. In these cases, the costs of false inclusions and false exclusions are much greater than the cost of a DNA analysis, so that it is worthwhile investing in an additional analysis even when the expectation for gaining additional information is very low. This occurs for high profile cases, where it is worthwhile obtaining as much information as possible regardless of the financial cost.
Sensitivity analyses of the utility function's preference structure and the probability of allele drop-in show minor fluctuations of the threshold value. A greater penalty for false designations (achieved by making the utility function's preference structure more conservative) gives the information content of the results of very small quantities of DNA less value because more information is needed to make informative genotype designations to reduce the risk of false genotype designations. Increasing the probability of allele drop-in increases the uncertainty on the donor's genotype for very small quantities of DNA, and this lowers the information content of the results. Hence a more conservative utility function and a higher probability of allele drop-in lower the EVOI of two replicates for very small quantities of DNA. This reduction in the EVOI of two replicates shifts the optimal choice towards a single analysis. In the all in vs. two replicates study, making the preference structure more conservative and raising the probability of allele drop-in therefore raises the threshold value of the minimum average allelic peak height in each of the replicates. For the additional replicate study, we distinguish between situations where m is the same order of magnitude as the cost (the threshold is around 43 rfu) and situations where m's order of magnitude is greater than the cost (the threshold is around 20 rfu or lower). In the first case, the decrease of the value of the information of the results of the first DNA analysis makes the information content of an additional replicate more valuable (i.e., increases the EVOI of an additional replicate), and hence slightly lowers the threshold. In the second case, the EVOI of the additional replicate decreases for very small quantities of DNA so that the cost of the DNA analysis no longer counterbalances its EVOI, and this slightly raises the threshold. With regard to the parameter values examined in this study (i.e., the symmetric vs. the conservative preference structure, and a probability of allele drop-in of 0.01 vs. 0.05 per locus), it is the utility function's preference structure that had the greater impact. It is possible that a larger probability of allele drop-in might have a larger impact than the results observed in this study, yet according to the values reported in the literature [e.g., 1, 3, 19, 20] , it is not reasonable to assume a probability of allele drop-in greater than 0.05 per locus.
The logistic regression curves for the two different kits were similar enough that there was no perceivable difference between the two amplification kits.
Conclusions
The results of this study indicate that two replicates generally have a greater ENG than a single DNA analysis for DNA quantities producing two replicates that each have an average allelic peak height of as low as 43 rfu. With regard to the all in vs. two replicates question, this means that the DNA analyst should split the DNA extract into two tubes to obtain two replicates when there is enough DNA that the expected allelic peak height in each replicate is at least 43 rfu. With regard to the additional replicate question, this means that it is worthwhile for the DNA analyst to invest in obtaining a second replicate when the expected average allelic peak height is greater than 43 rfu. This value of 43 rfu should be taken as a general indication that applies to many of the scenarios examined in this study, and not as an absolute threshold value. Sensitivity analyses show that the threshold value depends to a large extent on the magnitude of the utility function, to a small extent on the preference structure of the utility function, and to a very small extent on the assigned probability of allele drop-in.
The target quantity of DNA for lt-DNA analyses in casework is 500 pg [21, 22] . The results of this study present the limits of this method for quantities between 0.25 and 10 pg (i.e., quantities that are 50 to 2000 times smaller than the target quantity). Hence, the threshold where a single DNA analysis becomes more rational than two replicates is at quantities of 2 to 3 orders of magnitude smaller than the target amount for lt-DNA.
The results of this study support Kokshoorn and Blankers [9] and Steele et al. [7] in that two replicates increase the information content with regard to a single DNA analysis, and thus provide more data for making inferences about the donor's genotype.
Disclaimer
Certain commercial equipment, instruments, and suppliers are identified in this paper to foster understanding. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose.
The EVOI necessary for addressing the "additional replicate" question, denoted EVOI(t +1 ), is the difference between the expected maximum utility with the DNA results of the additional replicate and expected maximum utility without these results. The following equation gives the EVOI of a second replicate given the results of the first analysis:
